|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-9-24
|
|
pubmed:abstractText |
To investigate the pharmacokinetics of bevacizumab in rabbits for three different routes of administrations: intravitreal injection, subconjunctival injection, and eye drops.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1552-5783
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4807-13
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19324856-Administration, Topical,
pubmed-meshheading:19324856-Angiogenesis Inhibitors,
pubmed-meshheading:19324856-Animals,
pubmed-meshheading:19324856-Antibodies, Monoclonal,
pubmed-meshheading:19324856-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:19324856-Biological Availability,
pubmed-meshheading:19324856-Conjunctiva,
pubmed-meshheading:19324856-Drug Administration Routes,
pubmed-meshheading:19324856-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19324856-Injections,
pubmed-meshheading:19324856-Rabbits,
pubmed-meshheading:19324856-Tissue Distribution,
pubmed-meshheading:19324856-Vascular Endothelial Growth Factor A,
pubmed-meshheading:19324856-Vitreous Body
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.
|
|
pubmed:affiliation |
Department of Ophthalmology, Kagawa University Faculty of Medicine, Kagawa, Japan. nomoto@med.kagawa-u.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
